Abstract:Accurately assessing the radiation level of tumors and surrounding tissues is of great significance for the optimization of clinical therapeutic interventions as well as minimizing the radiation-induced side effects. Therefore, the development of noninvasive and sensitive biological dosimeters is vital to achieve quantitative detection of a radiation dose in a living system. Herein, as a proof of concept, we report a tumor-targeted and caspase-3-activatable NIR fluorogenic probe AcDEVD-Cy-RGD consisting of a hemicyanine fluorophore as a signal reporter, a caspase-3 specific Asp-Glu-Val-Asp (DEVD) peptide, and a cyclic Arg-Gly-Asp peptide (cRGD) for tumor targeting. Upon cleavage with activated caspase-3, this probe not only displays the lighted-up NIR fluorescence, but also ratiometric photoacoustic (PA710/PA680) signals concurrently in a caspase-3 concentration-dependent manner, allowing for sensitive and quantitative detection of caspase-3 activity through both fluorescence and PA imaging, which provides the possibility for real-time monitoring of tumor cell apoptosis in a living system. More notably, we utilized this probe to successfully realize the direct visualization of tumor response to chemo- or radiotherapy and, for the first time, achieve the accurate estimation of radiation doses imparted to the tumors. We thus believe that our current strategy would offer an attractive and valuable means for the precise assessment of locally delivered radiation doses in various clinical settings.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.2c00098.Synthetic methods, synthetic routes, characterizations of all compounds; Stability and enzyme reaction of AcDEVD-Cy-RGD; HR-MS spectrum of NH2-Cy-RGD; Fluorescence emission spectra of AcCy-RGD; TEM images and UV–vis absorption spectra of the probe; UV–vis absorption spectra, hydrodynamic size, and TEM of AcCy-RGD; CLSM images of 4T1 cells treated with various doses of DOX; Fluorescence imaging quantification of Figure 2b; Confocal images of 4T1 cells with or without X-ray irradiation; Fluorescence imaging quantification of Figure 2d; Immunohistochemical analysis of tumorous tissues from radiation-treated mice; PA spectra of the probe aqueous solution; Ratiometric PA imaging of drug-induced tumor apoptosis; Western blot analysis of DOX-induced tumor apoptosis; Ratiometric PA imaging of radiation-induced tumor apoptosis (PDF)This article has not yet been cited by other publications.

Targeted Theranostic Platinum(Iv) Prodrug With A Built-In Aggregation-Induced Emission Light-Up Apoptosis Sensor For Noninvasive Early Evaluation Of Its Therapeutic Responses In Situ

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

Engineering Molecular Self-Assembly of Theranostic Nanoprobes for Dual-Modal Imaging-Guided Precise Chemotherapy

A Cascade Enzymatic Reaction Activatable Gemcitabine Prodrug with an AIE-based Intracellular Light-Up Apoptotic Probe for in Situ Self-Therapeutic Monitoring

All-in-One Molecular Aggregation-Induced Emission Theranostics: Fluorescence Image Guided and Mitochondria Targeted Chemo- and Photodynamic Cancer Cell Ablation

Controlled sequential in situ self-assembly and disassembly of a fluorogenic cisplatin prodrug for cancer theranostics

A Theranostic Prodrug Based on FRET for Real-Time Drug Release Monitoring in Response to Biothiols.

Light‐Up Probe for Targeted and Activatable Photodynamic Therapy with Real‐Time In Situ Reporting of Sensitizer Activation and Therapeutic Responses

A Polyplatin with Hands-Holding Near-Infrared-II Fluorophores and Prodrugs at a Precise Ratio for Tracking Drug Fate with Realtime Readout and Treatment Feedback

Intelligent Nanoprobe: Acid-Responsive Drug Release and In Situ Evaluation of Its Own Therapeutic Effect

In Vivo and in Situ Tracking Cancer Chemotherapy by Highly Photostable NIR Fluorescent Theranostic Prodrug

Folate Receptor-Targeted and Cathepsin B-Activatable Nanoprobe for in Situ Therapeutic Monitoring of Photosensitive Cell Death

An AIEgen and Iodine Double-Ornamented Platinum(II) Complex for Bimodal Imaging-Guided Chemo-Photodynamic Combination Therapy

Light-up Bioprobe with Aggregation-Induced Emission Characteristics for Real-Time Apoptosis Imaging in Target Cancer Cells.

In Vivo Quantitative Assessment of a Radiation Dose Based on Ratiometric Photoacoustic Imaging of Tumor Apoptosis

Biotin and boron-dipyrromethene-tagged platinum(IV) prodrug for cellular imaging and mito-targeted photocytotoxicity in red light

A Ph-Activatable And Aniline-Substituted Photosensitizer For Near-Infrared Cancer Theranostics

A Theranostic Prodrug Delivery System Based on Pt(IV) Conjugated Nano-Graphene Oxide with Synergistic Effect to Enhance the Therapeutic Efficacy of Pt Drug

Enzyme-triggered supramolecular self-assembly of platinum prodrug with enhanced tumor-selective accumulation and reduced systemic toxicity

Image-guided Combination Chemotherapy and Photodynamic Therapy Using a Mitochondria-Targeted Molecular Probe with Aggregation-Induced Emission Characteristics

NIR Light and GSH Dual-Responsive Upconversion Nanoparticles Loaded with Multifunctional Platinum(IV) Prodrug and RGD Peptide for Precise Cancer Therapy